Clinical Trials Insight: 700058270
Phase of Trial: Phase I
Latest Information Update: 12 Nov 2010
At a glance
- Drugs DRL 17822 (Primary)
- Indications Atherosclerosis; Chronic obstructive pulmonary disease; Dyslipidaemias
- Focus Adverse reactions
- Sponsors Dr Reddys Laboratories
- 29 Jun 2010 New trial record.
- 29 Jun 2010 Results were reported at the 70th Annual Scientific Sessions of the American Diabetes Association.